Company Profiles

driven by the PitchBook Platform

Xeris Pharmaceuticals

Description

Developer of a glucagon rescue pen for emergency treatment of severe hypoglycemia. The company develops injectable drugs based on its non-aqueous XeriJect and XeriSol formulation and delivery platforms.

2005

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$71M

Latest Deal Amount

$94.3M

Total Amount Raised

Description

Developer of a glucagon rescue pen for emergency treatment of severe hypoglycemia. The company develops injectable drugs based on its non-aqueous XeriJect and XeriSol formulation and delivery platforms.

Website:

www.xerispharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

3208 Red River Street Suite 300 Austin, TX 78705United States +1 (512) 498-2670
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Xeris Pharmaceuticals's full profile, request a free trial.

Xeris Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Xeris Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Xeris Pharmaceuticals Investors (13)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Annex VenturesVenture CapitalMinority000 0000000 0000
Asahi KaseiCorporationMinority000 0000000 0000
Austin Technology IncubatorAccelerator/Incubator000 0000000 0000
Bay City CapitalVenture CapitalMinority000 0000000 0000
Central Texas Angel NetworkAngel GroupMinority000 0000000 0000
Annex Ventures Venture Capital
Asahi Kasei Corporation
Austin Technology Incubator Accelerator/Incubator
Bay City Capital Venture Capital
Central Texas Angel Network Angel Group

Xeris Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Paul EdickChief Executive Officer, Board Member & President
Yash Sabharwal Ph.DChief Operating Officer & Chief Financial Officer
Phillip JohnsonChief Financial Officer
Steven Prestrelski Ph.DChief Scientific Officer, Co-Founder & Director
John Kinzell Ph.DExecutive Vice President, Corporate Development, Director & Co-Founder
Paul Edick Chief Executive Officer, Board Member & President
Yash Sabharwal Ph.D Chief Operating Officer & Chief Financial Officer
Phillip Johnson Chief Financial Officer
Steven Prestrelski Ph.D Chief Scientific Officer, Co-Founder & Director
John Kinzell Ph.D Executive Vice President, Corporate Development, Director & Co-Founder

Xeris Pharmaceuticals Board Members (3)

NameRepresentingRoleSinceContact
Info
Navneet Puri Ph.DSelfBoard Member000 0000
Robert FaulknerRedmile GroupManaging Director000 0000
Shane BrisbinSelfDirector000 0000
Navneet Puri Ph.D Board Member Self
Robert Faulkner Managing Director Redmile Group
Shane Brisbin Director Self
Request full access to PitchBook